As of 2024-12-14, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 47.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.39 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 45.7%.
The range of the Relative Valuation is 30.49 - 80.00 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 20.4x | 16.6x |
| Forward P/E multiples | 10.9x - 21.9x | 16.1x |
| Fair Price | 30.49 - 80.00 | 47.20 |
| Upside | -5.9% - 147.0% | 45.7% |
| Date | P/E |
| 2024-12-13 | 15.06 |
| 2024-12-12 | 14.82 |
| 2024-12-11 | 15.02 |
| 2024-12-10 | 15.21 |
| 2024-12-09 | 15.57 |
| 2024-12-06 | 15.70 |
| 2024-12-05 | 15.58 |
| 2024-12-04 | 16.24 |
| 2024-12-03 | 16.05 |
| 2024-12-02 | 16.34 |
| 2024-11-29 | 16.12 |
| 2024-11-27 | 16.63 |
| 2024-11-26 | 16.20 |
| 2024-11-25 | 16.14 |
| 2024-11-22 | 15.85 |
| 2024-11-21 | 15.45 |
| 2024-11-20 | 15.25 |
| 2024-11-19 | 15.11 |
| 2024-11-18 | 15.38 |
| 2024-11-15 | 15.45 |
| 2024-11-14 | 15.35 |
| 2024-11-13 | 15.74 |
| 2024-11-12 | 16.31 |
| 2024-11-11 | 16.70 |
| 2024-11-08 | 16.78 |
| 2024-11-07 | 16.24 |
| 2024-11-06 | 15.95 |
| 2024-11-05 | 15.54 |
| 2024-11-04 | 15.37 |
| 2024-11-01 | 15.38 |
| 2024-10-31 | 14.94 |
| 2024-10-30 | 15.72 |
| 2024-10-29 | 19.30 |
| 2024-10-28 | 16.63 |
| 2024-10-25 | 16.05 |
| 2024-10-24 | 15.84 |
| 2024-10-23 | 15.84 |
| 2024-10-22 | 16.21 |
| 2024-10-21 | 16.25 |
| 2024-10-18 | 16.47 |
| 2024-10-17 | 16.26 |
| 2024-10-16 | 16.20 |
| 2024-10-15 | 16.51 |
| 2024-10-14 | 16.50 |
| 2024-10-11 | 16.20 |
| 2024-10-10 | 16.19 |
| 2024-10-09 | 15.63 |
| 2024-10-08 | 16.16 |
| 2024-10-07 | 15.99 |
| 2024-10-04 | 16.09 |